Yun Sil Chang

This inventor holds 13 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Stem Cell Therapy. Top assignees: Samsung Life Public Welfare Foundation, Medinno Inc., Medipost Co., Ltd. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yun Sil Chang. Retrieved from https://idiyas.com/inventor/yun-sil-chang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 4)

% Patents Active = 92.3

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

12 out of 146

Samsung Life Public Welfare Foundation

Pusan National University

patents

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Exosomes

Stem Cells

Infectious Diseases

Bronchopulmonary Dysplasia

Hyperoxia

Cerebrovascular Diseases

Chronic Pulmonary Disease

Inflammatory Brain Diseases

Therapeutic Substances

Neonatal HIE

Thrombin

Cell Therapy

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734195 - Composition for treating infectious diseases, comprising exosomes derived from thrombin-treated stem cells (2026-09-15),

2. 12239695 - Composition comprising thrombin-treated stem cell-derived exosome for treating skin wound (2025-03-04),

3. 12031976 - Screening method for therapeutic substance for preventing or treating bronchopulmonary dysplasia (BPD) (2024-07-09),

4. 12000825 - Method of selecting stem cells having ability to produce extracellular vesicles with high efficiency using activation of protease-activated receptor-mediated signaling pathways (2024-06-04),

5. 11833176 - Composition for treating neonatal HIE (2023-12-05),

6. 10765720 - Composition for preventing or treating hyperoxia-induced lung injury comprising WKYMVm peptide as an active ingredient (2020-09-08),

7. 10723997 - Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell (2020-07-28),

8. 10493104 - Composition for treating inflammatory brain diseases which includes stem cell as active ingredient (2019-12-03),

9. 10167448 - Pharmaceutical composition for treating cerebrovascular diseases, containing stem cell-derived exosome as active ingredient (2019-01-01),

10. 9982233 - Method for promoting generation of stem cell-derived exosome by using thrombin (2018-05-29),

11. 9919011 - Method for treating an inflammatory brain disease comprising administering a stem cell-derived exosome (2018-03-20),

12. 9539285 - Composition for treating intraventricular hemorrhage in preterm infants comprising mesenchymal stem cells (2017-01-10),

13. 9498497 - Method of treating lung diseases using cells separated or proliferated from umbilical cord blood (2016-11-22),

Title: Inventor Yun Sil Chang

Introduction: Yun Sil Chang is a renowned inventor based in Seoul, South Korea, known for his groundbreaking innovations in various fields.

Latest Patents: Yun Sil Chang holds several patents in the areas of technology and healthcare, with his most recent inventions focusing on sustainable energy solutions and medical devices.

Career Highlights: With a career spanning over two decades, Chang has been instrumental in developing cutting-edge technologies that have significantly impacted industries worldwide. His contributions to the field of renewable energy and biotechnology have earned him international recognition.

Collaborations: Throughout his career, Yun Sil Chang has collaborated with leading research institutions, universities, and multinational companies to further advance his inventions. His collaborative efforts have resulted in the successful commercialization of several patented technologies.

Conclusion: Inventor Yun Sil Chang's dedication to innovation and his passion for creating solutions to global challenges have solidified his reputation as a pioneering figure in the world of inventions.

Profile summary based on public USPTO records.